MFPVP

MFPVP is a psychoactive drug that belongs to the cathinone class. It is a synthetic stimulant that is also known as 3',4'-Methylenedioxy-α-pyrrolidinohexiophenone. MFPVP is a new psychoactive substance (NPS) that has recently emerged on the illicit drug market.

Chemistry

MFPVP is a cathinone derivative, which is a group of drugs that are primarily central nervous system (CNS) stimulants. Cathinones are beta-ketone analogues of amphetamines. MFPVP is chemically related to pyrovalerone and is the higher homolog of MDPPP, with the phenyl ring replaced by a benzodioxole ring.

Pharmacology

The pharmacology of MFPVP is largely unknown as it is a new psychoactive substance. However, it is believed to work as a norepinephrine-dopamine reuptake inhibitor (NDRI), similar to other cathinones. This means it increases the levels of the neurotransmitters norepinephrine and dopamine in the brain by inhibiting their reuptake into neurons.

Effects

The effects of MFPVP can vary greatly depending on the dose, the user's individual physiology, and the method of administration. However, common effects reported by users include stimulation, euphoria, increased alertness and focus, and increased sociability. Some users also report experiencing negative effects such as anxiety, paranoia, and insomnia.

Risks and Legal Status

As a new psychoactive substance, the risks associated with MFPVP use are not fully known. However, it is likely that they are similar to those of other stimulant drugs, which can include addiction, psychosis, and physical harm. MFPVP is currently not controlled under international drug treaties, but it may be controlled in some countries under analogue laws or specific legislation.

See Also

• Cathinone
• MDPPP
• Norepinephrine-dopamine reuptake inhibitor
• New psychoactive substance